ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,555.74
      -0.16%
      US Tech 100
      19,189.60
      -0.53%
      Dow Jones
      40,358.09
      -0.14%
      Brent Oil
      80.775
      -0.91%
      Bitcoin
      65,990.04
      -2.39%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. Innate Pharma (IPH) Quote

      Innate Pharma

      Innate Pharma (IPH)

      IPH Limited
      2.14
      0.00
      (0.00%)
      Closed July 23 11:30AM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      2.14
      Bid
      2.12
      Ask
      2.145
      Volume
      53,885
      2.125 Day's Range 2.15
      1.862 52 Week Range 3.04
      Market Cap
      680.885M
      Previous Close
      2.14
      Open
      2.15
      Last Trade
      1
      @
      2.14
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      75,525
      Shares Outstanding
      318,170,508
      Dividend Yield
      -
      PE Ratio
      -89.92
      Earnings Per Share (EPS)
      -0.02
      Revenue
      61.64M
      Net Profit
      -7.57M

      About Innate Pharma

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.innate-pharma.com
      Headquarters
      Marseille, Bouches-du-rhone, Fra
      Founded
      1970
      Innate Pharma is listed in the Biological Pds,ex Diagnstics sector of the Euronext with ticker IPH. The last closing price for Innate Pharma was 2.14 €. Over the last year, Innate Pharma shares have traded in a share price range of 1.862 € to 3.04 €.

      Innate Pharma currently has 318,170,508 shares outstanding. The market capitalization of Innate Pharma is 680.88 € million. Innate Pharma has a price to earnings ratio (PE ratio) of -89.92.

      IPH Latest News

      More News

      Number of Shares and Voting Rights of Innate Pharma as of June 10, 2024

      Regulatory News: Pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers, or “AMF”...

      June 18 2024
      Business Wire

      Innate Pharma Shares Updated Results From the Sanofi Developed Blood Cancer Phase 1/2 SAR443579/IPH6101 Trial

      SAR443579/IPH6101, ANKET® platform lead asset, is a first-in-class NKp46/CD16-based NK cell engager targeting CD123 from a joint research collaboration between Innate Pharma and Sanofi, under...

      June 17 2024
      Business Wire

      Innate Pharma présente les résultats positifs de l’étude de Phase 2 TELLOMAK évaluant lacutamab dans le mycosis fongoïde

      Le traitement avec lacutamab montre une activité antitumorale cliniquement significative chez les patients atteints d’un mycosis fongoïde lourdement prétraités, indépendamment du niveau...

      June 04 2024
      Business Wire

      Innate Pharma annonce sa participation à de prochaines conférences investisseurs

      Regulatory News: Innate Pharma SA (Euronext Paris : IPH ; Nasdaq : IPHA) (« Innate » ou la « Société ») annonce aujourd’hui que des membres de son équipe de direction, parmi lesquels Hervé...

      May 28 2024
      Business Wire

      Innate Pharma partage les abstracts sélectionnés pour le congres annuel de l’ASCO 2024

      Données finales de l’essai de Phase 2 TELLOMAK dans le mycosis fongoïde confirmant l’activité clinique prometteuse de lacutamab Deux posters concernant IPH6501, la molécule ANKET® de seconde...

      May 24 2024
      Business Wire

      Outcome of Innate Pharma’s 2024 Annual General Meeting

      Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) announced the voting results of its shareholders at the Annual General Meeting (“AGM”), which...

      May 23 2024
      Business Wire

      Innate Pharma: Clarification concernant le statut de SAR443579

      Regulatory News: Innate Pharma SA (Euronext Paris : IPH ; Nasdaq : IPHA) (« Innate » ou la « Société ») a annoncé aujourd’hui qu’un abstract publié le 14 mai 2024 en amont du congrès de...

      May 21 2024
      Business Wire

      Innate Pharma partage les abstracts sélectionnés pour le congrès 2024 de l’EHA

      Deux abstracts concernant SAR443579 (IPH6101), le candidat-médicament le plus avancé de la plateforme ANKET®, un NK Cell Engager trifonctionnel engageant les récepteurs NKp46/CD16 et ciblant...

      May 15 2024
      Business Wire

      Innate Pharma Shares Rise after Sanofi Exercises Licensing Option

      By Dean Seal Innate Pharma's American depositary receipts rose after the company said Sanofi had exercised its option to license a natural killer cell engager program in solid tumors from...

      December 19 2023
      Dow Jones News

      Innate Pharma Shares Fall Premarket on FDA Partial Study Hold

      By Colin Kellaher Shares of Innate Pharma dropped in premarket trading Thursday after the biopharmaceutical company said the U.S. Food and Drug Administration placed a partial hold on studies of...

      October 05 2023
      Dow Jones News
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.073.381642512082.072.152.005293632.08288393DE
      40.14722.151.862467842.00678276DE
      12-0.105-4.677060133632.2452.791.862755252.34520412DE
      26-0.34-13.70967741942.482.791.862694792.31589911DE
      52-0.775-26.58662092622.9153.041.862870222.42021444DE
      156-0.61-22.18181818182.755.7351.8621954493.4209847DE
      260-3.56-62.45614035095.77.51.8622642334.10857738DE

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ALLRAllarity Therapeutics Inc
      $ 0.32
      (92.19%)
      		36.93M
      NIVFNewGenIvf Group Ltd
      $ 1.44
      (65.35%)
      		3.81M
      NUZENuZee Inc
      $ 1.50
      (45.63%)
      		237.83k
      SLNASelina Hospitality PLC
      $ 0.03165
      (21.73%)
      		38.9M
      DRMADermata Therapeutics Inc
      $ 1.53
      (17.69%)
      		94.33k
      VSTMVerastem Inc
      $ 2.74
      (-23.68%)
      		376.59k
      SLRXSalarius Pharmaceuticals Inc
      $ 2.17
      (-16.86%)
      		207.47k
      MINMMinim Inc
      $ 2.43
      (-14.74%)
      		18.39k
      ALPPAlpine 4 Holdings Inc
      $ 0.512
      (-14.65%)
      		292.67k
      CJETChijet Motor Company Inc
      $ 4.35
      (-14.37%)
      		88.64k
      SLNASelina Hospitality PLC
      $ 0.03165
      (21.73%)
      		38.9M
      ALLRAllarity Therapeutics Inc
      $ 0.32
      (92.19%)
      		36.93M
      TSLATesla Inc
      $ 234.80
      (-4.70%)
      		12.35M
      TSLLDirexion Daily TSLA Bull 2X Trust ETF
      $ 12.4297
      (-9.27%)
      		10.49M
      HOLOMicroCloud Hologram Inc
      $ 0.595
      (1.74%)
      		8.57M

      Discussion

      View Full Feed
      MrAce MrAce 2 minutes ago
      .20 by Friday??
      KBLB
      Going_4_It Going_4_It 2 minutes ago
      NuScale bid on building Ghana's first nuclear reactor.

      "Why-Everyone-Wants-a-Piece-of-Ghanas-Nuclear-Energy-Sector."

      Article from July 16:

      https://oilprice.com/Alternative-Energy/Nuclear-Power/Why-Everyone-Wants-a-Piece-of-Ghanas-Nuclear-Energy-Sector.htm
      SMR
      bgoat bgoat 2 minutes ago
      Hey Jazz, I hope they do! That will bring more attention to how massive this is!!! tick tick tick ...BOOM!!
      SPZI
      chuck4345 chuck4345 2 minutes ago
      Not in our lifetime
      SHIBUSD
      blackhawks blackhawks 2 minutes ago
      Vance is worse. The contemptuous remarks he made about Trump in '16 were prescient. He is an unprincipled, ends justify the means, windsock and a moral imbecile. Similar to Trump, but worse for someone with a law degree.

      J.D do your Emily Litella: The VP slot?! Oh, that's very differe
      blackhawks blackhawks 2 minutes ago
      Vance is worse. The contemptuous remarks he made about Trump in '16 were prescient. He is an unprincipled, ends justify the means, windsock and a moral imbecile. Similar to Trump, but worse for someone with a law degree.

      J.D do your Emily Litella: The VP slot?! Oh, that's very differe
      MRJ25 MRJ25 3 minutes ago
      If...after a jury has condemned the FHFA for the third amendment (in the case of fannie pfd's, with interest since it was signed), it would be very strange if the third amendment continued to be valid.

      Yes, I am not a lawyer, but some other people here have mentioned that if this ruli
      FNMA
      ergo sum ergo sum 3 minutes ago
      Suddenly the whole country things the NYT was right in the first place.
      madras50 madras50 3 minutes ago
      So is there any similarity in their story?
      SLNA
      theorysuit theorysuit 4 minutes ago
      Dude you are paranoid beyond belief. Nothing you say or i say means anything. Ultimately the company must execute, and it sure doesn't look like they can. The focus has always been on LP and her enrichment.
      NWBO
      ksquared ksquared 5 minutes ago
      Kamala Harris Supporters Fear Democrat Women Losing Elections Causes PTSD
      (Oh, puh-leeze...)
      AMY FURR 23 Jul 2024 2:22 Some social media users who commented on the Occupy Democrats post did not appear to be on board with a possible Harris presidency... “No one voted f
      weedisgreen weedisgreen 5 minutes ago
      I think it will pop up to that when they announce uplisting and then come down with a slow rise back up. Back in the spring a watched a podcast at some event that talked to a tune of the institutional investors already doing their homework. I'm also feeling confident that Kim already has been gett
      TCNNF
      capgain capgain 6 minutes ago
      Could very well be. It wouldn't surprise me any, and we'll probably never know.
      Jaxxm Jaxxm 6 minutes ago
      Maybe tomorrow 1 dollar plus
      HOLO
      CaptBeer CaptBeer 6 minutes ago
      $AMRN Here’s a fun Bonus Graphic showing the first 10-month Launch of VASCEPA® (USA) vs. VAZKEPA® (UK). VASCEPA® Launched in the USA in January 2013 and VAZKEPA® launched in October 2022.
      For comparison purposes, consider:

      1. Potential Patient Populations.
      AMRN
      thistraderknowsall thistraderknowsall 7 minutes ago
      #1 MOMO BREAKOUT..ASM Altcoin to $1 online in a few minutes !!! We win!! Congrats!!!
      ASM
      Lone Clone Lone Clone 8 minutes ago
      ARK, OGC, SNAG, ODV, TUO

      Kazakhstan explorer Arras Minerals aka ARK announced the initiation of an airborne geophysical survey across its Maisor and Aktasty properties, which cover 1397 sq km and are part of the Exploration Alliance with Teck. They surround the large operating Bozshak
      TUD
      HyGro HyGro 8 minutes ago
      Except for the 8 peer reviewed articles that challenge the legitimacy of the clinical trial revisions done 2 weeks before the completion of the trial.

      Totally new comparator (one required to be approve BEFORE the trial started), change the protocol, endpoints, and experimental design
      NWBO
      devil dog 96 devil dog 96 8 minutes ago
      This is all lies. 😆 I have never seen so many lies in one post 🤡 LMAO

      " I’ve not ever bought this pig, ,not as pos tron.
      Not as pos atmh.
      Nor would I ever.
      Only a freakin moron would.imo "

      The no proof scam theory promo is a total sh
      ATMH
      Hercules1 Hercules1 8 minutes ago
      What happened to water chaser?


      Let me take a guess:

      He is covered in shit.

      From shitting all over himself.
      HIRU
      shigtynodigty shigtynodigty 9 minutes ago
      I am hoping that reverse split doesn’t happen in 2 years and they can get over the 1.00 price
      CHUC
      FACT-MASTER FACT-MASTER 9 minutes ago
      BLX: AH Price/Volume on FIRE!!

      Last at $35.05 / 31,000 shares traded AH. ( at the moment)

      https://www.nasdaq.com/market-activity/stocks/blx/after-hours
      BLX
      shigtynodigty shigtynodigty 9 minutes ago
      Big time
      CHUC
      jazz5201 jazz5201 10 minutes ago
      Bashers are going to be working overtime tonight to twist and turn things.

      This is just the beginning.

      Pennies soon...
      SPZI

      Your Recent History

      EU
      IPH
      Innate Pharma
      LSE
      SLET
      Standard Life Equity Income
      BIT
      UB2Y53
      UniCredit Bank
      USOTC
      ECAOF
      Eco Atlantic Oil (PK)
      NASDAQ
      FFIN
      First Financial Bankshares
      Delayed Upgrade Clock